Protection of Human Subjects and Institutional Review Boards
Revision of a currently approved collection
No
Regular
Approved with change
03/10/2023
01/24/2023
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
03/31/2026
36 Months From Approved
03/31/2023
346,828
0
346,800
1,626,803
0
1,731,430
0
0
147,171,550
The information collection supports implementation of statutory and regulatory requirements pertaining to the rights and welfare of human subjects involved in FDA-regulated research, and applicable to Institutional Review Boards that oversee such research. Respondents to the information collection are sponsors, members, or other individuals subject to the applicable requirements and FDA regulations in 21 CFR parts 50 and 56
US Code:
21 USC 301 et. seq.
Name of Law: Federal Food, Drug, and Cosmetic Act
US Code:
42 USC 241; 289
Name of Law: Public Health and Welfare; Institutional Review Boards
PL: Pub.L. 114 - 255 301(d) Name of Law: 21st Century Cures Act
Cumulatively, changes to the information collection result in an additional 28 responses and a reduction of 104,655 hours annually to the information collection. These changes are discussed more fully in the agency's SSA.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.